Clinical trial
MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)
NCT00157729 · Medicure, Industry · Completed
Key facts
| NCT number | NCT00157729 |
|---|---|
| Title | MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics) |
| Official title | Evaluation of the Effects of MC-1 Alone and in Combination With an ACE Inhibitor on Ambulatory Blood Pressure and Metabolic Function in Hypertensive Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | Medicure, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus Type 2, Hypertension, Metabolic Syndrome |
| Intervention type | Drug |
| Interventions | pyridoxal-5'-phosphate with and without ACE inhibitor |
| Enrollment | 160 |
| Start date | Aug 1, 2004 |
| Completion | Jul 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Oct 31, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: